期刊
INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY
卷 20, 期 2, 页码 240-248出版社
SPRINGER JAPAN KK
DOI: 10.1007/s10147-015-0806-7
关键词
Uterine cervical cancer; Clinical practice guidelines; Surgery; Chemotherapy; Irradiation; Recurrence
类别
资金
- Ministry of Health, Labour and Welfare [H24-Clinical Cancer Research-001]
- Grants-in-Aid for Scientific Research [26462538] Funding Source: KAKEN
The second edition of the Japan Society of Gynecologic Oncology guidelines for the treatment of uterine cervical cancer was published in 2011. The guidelines comprise eight chapters and five algorithms. They were prepared by consensus among the members of the Japan Society of Gynecologic Oncology Guidelines Formulation Committee and Evaluation Committee and are based on a careful review of the evidence obtained from the literature, health insurance system, and actual clinical settings in Japan. The highlights of the 2011 revision are (1) the recommended grades have been changed to five stages-A, B, C1, C2, and D; (2) the revisions are consistent with the new International Federation of Gynecology and Obstetrics staging system; (3) the roles are shared between the 'Japanese classification of cervical cancer' and the new guidelines; (4) clinical questions related to adenocarcinoma have been revised; and (5) a clinical question regarding cervical cancer in pregnant patients has been added. Each chapter includes a clinical question, recommendations, background, objectives, explanations, and references. Each recommendation is accompanied by a classification of recommendation categories. The objective of these guidelines is to update the standard treatment strategies for cervical cancer, thus eliminating unnecessary and insufficient treatment.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据